Biotech Values

[DewDiligence]

GILD—It can't be that all these patients who got on Sovaldi+IFN were desperate to get treated in these six to nine months.

It’s been only 112 days since FDA approval of Sovaldi (#msg-99677002), which is too soon (IMO) to be making a broad statement that IFN is less of an impediment to treatment than previously thought.